2023-07-14T13:32:00+01:00
Device that detects Sars-CoV-2 could be adapted to monitor other respiratory pathogens
2023-06-29T13:58:00+01:00
IBM model can also find molecules that bind at different sites on target proteins
2023-06-22T11:45:00+01:00
Discovering the potential of mangroves and myself
2023-05-19T12:45:00+01:00
Amie Fornah Sankoh has persevered from failing primary school in Sierra Leone to gaining a biochemistry PhD in the US
2023-05-19T08:33:00+01:00
The pharmaceutical executive on why chemistry clicked for her, and life as a female organic chemist in the drug industry
2023-03-23T09:30:00+00:00
Covid-19 can be detected with the sensitivity of PCR and the ease of lateral flow
2023-01-09T13:30:00+00:00
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
2022-12-14T15:33:00+00:00
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
2022-09-26T08:32:00+01:00
The finishing line of the Covid-19 pandemic may be in sight, but we mustn’t stop running just yet
This series of Chemistry World reports is part of a forth coming e-book and hardback to be published by the Royal Society of Chemistry. The book was motivated by a desire on the part of the editors and the authors to produce a body of information on the new and deadly coronavirus about which the world was largely uninformed and for which it was totally unprepared.
2020-07-31T22:10:00+01:00By Ben Valsler
Originally developed to treat flu and marketed in Japan as Avigan, promising Covid-19 trial results have seen countries stockpiling this medication by the millions
Source: © StreetVJ / Shutterstock.com
2022-09-16T08:30:00+01:00
Report raises awkward questions about prominent study on antimalarial conducted in Didier Raoult’s lab
2022-08-19T08:50:00+01:00
The medicinal chemist on thinking like a scientist and knowing where you want to go
2022-08-09T12:55:00+01:00
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
2022-06-24T08:30:00+01:00
The impact of Covid-19 on fundraising efforts sees charities slash research support
2022-06-23T13:30:00+01:00
Analysis comparing Sputnik results with five other Covid vaccines finds phase 3 trial outcome is highly improbable
2022-06-14T13:00:00+01:00
The tangled web of fine chemicals supply frequently throws up surprises
2022-06-01T08:24:00+01:00
But are often overlooked in celebrations of research excellence
2022-05-31T13:14:00+01:00
Firms anticipate long-term markets for prevention and treatment
2022-04-12T14:45:00+01:00
Pharmaceutical firm Catalent buys government-backed facility near Oxford
2022-01-27T09:36:00+00:00
Following the Covid-19 pandemic, is it time to rethink events for good?
2021-12-16T15:02:00+00:00
It’s been another dramatic, pandemic-dominated year for the pharmaceutical industry
2021-11-12T14:17:00+00:00
Promising results from Pfizer trial, while UK approves Merck & Co’s molnupiravir
2021-10-08T13:28:00+01:00
Merck & Co and Ridgeback’s molnupiravir reduces risk of hospitalisation and death, and may work against other coronaviruses
2021-09-30T13:29:00+01:00
Small molecules appear to be lagging behind development of vaccine and antibody treatments
2021-09-28T08:30:00+01:00
Emphathy is vital to support mentees effectively
2021-09-23T13:30:00+01:00
Data-crunching goes up against gut feeling as the chemistry community weighs in on their favourites for the world’s top chemistry prize
2021-09-22T10:17:00+01:00
How an intrepid group of technicians adventured into the world of filmmaking
2021-09-14T08:00:00+01:00
As it gets cheaper and easier to read genetic code, its applications are expanding rapidly
2021-09-09T13:32:00+01:00
The benefits and drawbacks of working or studying from home are not clear cut
2021-09-02T13:30:00+01:00
After months of investigation agencies remain divided on most likely origin of Sars-CoV-2
2021-09-02T08:30:00+01:00
WHO calls for delay to booster programmes to allow more global distribution
2021-08-27T08:30:00+01:00
Drugs that block infection or reduce inflammation will complement vaccine protection
2021-08-13T12:54:00+01:00
Researchers reported spending more time on peer-review activities, teaching and writing
2021-08-11T08:29:00+01:00
Lack of funds and local manufacturing capacity has prevented Covax from competing with wealthier nations’ self-interest
2021-07-23T08:37:00+01:00
The Canadian biomedical engineer on failure, politics and celebrity science
Site powered by Webvision Cloud